Matthew has worked in investment banking for over 15 years with Robey Warshaw, Goldman Sachs and Merrill Lynch, advising on over $300bn of M&A transactions and over $3bn of equity fundraising. Matthew joined the Board of Trustees of Prostate Cancer Research in July 2016 and has been Chair since July 2018.